Results 211 to 220 of about 33,100 (246)

Molecular Pharmacology of Human Metabolism Diseases. [PDF]

Int J Mol Sci
Bułdak Ł.
europepmc   +1 more source

Anticancer and Anti-Inflammatory Effects of Benzothiazole Derivatives Targeting NF-κB/COX-2/iNOS in a Hepatocellular Carcinoma Cell Line. [PDF]

Turk J Pharm Sci
Üremiş MM, Üremiş N, Ceylan M, Türköz Y.   +3 more
europepmc   +1 more source

Splicing factor PTBP1 promotes hepatocarcinogenesis via oncogenic splice-switching of MAPT. [PDF]

Oncol Res
Zheng W, Shang Y, DU K, Luo A, Pei L, Li M, Zhang G, Deng M.   +7 more
europepmc   +1 more source

Sebaceous carcinoma: clinical and demographic profile of patients in a tertiary referral hospital in Brazil. [PDF]

An Bras Dermatol
Yendo TM, Damiani FM, Matayoshi S, Nico MMS.   +3 more
europepmc   +1 more source

[⁹⁰Y]Y-L4-Lipo/ ethyl esters of Iodized fatty acids of poppy seed oil (lipiodol^® ultra-fluid), a new TARE formulation, designed from a lipophilic ligand for stability and safety. [PDF]

EJNMMI Radiopharm Chem
Fougère O, Dencausse A, Lepareur N, Van Simaeys G, Doumont G, Gardin I, Renard E, Hollenbeck C, De Maeseneire C, Passon N, Rousseaux O, Catoen S.   +11 more
europepmc   +1 more source

[Tamoxifen and hepatocarcinoma].

Revista de gastroenterologia de Mexico, 1999
openaire   +1 more source

Fast-Acting Chalcogen-Phosphoranes Inhibit Sensitive and Resistant <i>Plasmodium falciparum</i> Strains. [PDF]

ACS Omega
Moura IMR, Barbosa CS, Mendes GR, Aguiar ACC, Cruz FC, Menezes PH, Guido RVC.   +6 more
europepmc   +1 more source

[Immunohistochemical studies in hepatocarcinomas].

Medicina, 1986
M I, Delfino, L, De Marco, S, Simian, A, Avagnina, B, Elsner   +4 more
openaire   +1 more source